GlassScriptPhysician profile
Marcela Riojas
NPI 1841456332
$954.29
in general payments reported to CMS, 2019-2025
23 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $44.76 · 2021: $563 · 2022: $55.52 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $197.36 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $95.19 | 2021 | |
| Alexion Pharmaceuticals, INC. | $69.25 | 2025 | Ultomiris |
| Novo Nordisk INC | $54.31 | 2021-2025 | Ozempic |
| Biohaven Pharmaceuticals, INC. | $42.30 | 2021 | |
| Lilly USA, LLC | $41.67 | 2021-2022 | |
| Abbvie INC. | $40.21 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $39.74 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.02 | 2021 | |
| Eisai INC. | $36.09 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $32.18 | 2025 | Breztri |
| Amarin Pharma, INC. | $29.81 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $29.34 | 2025 | Caplyta |
| Romark Laboratories, Lc | $29.33 | 2020 | |
| Ibsa Pharma INC. | $28.95 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $27.94 | 2021 | |
| Hologic Sales and Service, LLC | $24.81 | 2022 | |
| Abbott Laboratories | $20.95 | 2021 | |
| Shire North American Group INC | $19.27 | 2019 | |
| Therapeuticsmd, INC. | $15.12 | 2019 | |
| Corcept Therapeutics | $14.84 | 2022 | |
| Astellas Pharma US INC | $14.00 | 2019 | |
| Medtronic, INC. | $13.61 | 2025 | Venaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcela Riojas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.